verbatim): This project addresses the composition and function of contractile proteins in myocardium and thus assess the role of the contractile apparatus in the evolution of ischemic cardiomyopathy. Human myocardial biopsy samples will be characterized microscopically and by protein composition in both ischemic and nonischemic remodeled zones with direct comparison to samples from control myocardium which demonstrate no evidence of regional coronary artery disease or global contractile deficit. The biopsies will be characterized with respect to changes in proportions of isoforms, alterations of normal stoichiometric ratios (reflecting loss of protein or excessive degradation), and alterations in phosphorylation of proteins. Native thin filaments and myosin will be isolated and purified from selected zones (ischemic, non-ischemic remodeled, and apparently normal zones), and characterized with respect to calcium sensitivity, unloaded shortening, and average force using the in vitro motility assay. Sarcomeric proteins will be isolated from explanted human hearts. The thin filament will be reconstituted and characterized with respect to contractile function, including average cross-bridge force, calcium activation, ATPase, and maximal unloaded shortening. The use of explanted tissue will allow characterization of specific contractile proteins and thus permit delineation of casual links between specific native thin filament changes and mechanical performance. The overall hypothesis to be tested is that alterations in contractile machinery within ischemic zones and nonischemic remodeled zones underlie changes in mechanical performance that contribute to progressive diminution in regional and global myocardial performance. The proposed research is designed to determine whether specific changes within the sarcomere (for example altered thin filament activation or changes in mechanical behavior of myosin) underlie the progression evident in ischemic myopathy. Such data could ultimately be used to identify specific targets for interventions designed to confer protection.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Cardiovascular and Pulmonary Research A Study Section (CVA)
Program Officer
Balshaw, David M
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Vermont & St Agric College
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Vanburen, Peter; Palmer, Bradley M (2010) Cooperative activation of the cardiac myofilament: the pivotal role of tropomyosin. Circulation 121:351-3
Okada, Yoko; Toth, Michael J; Vanburen, Peter (2008) Skeletal muscle contractile protein function is preserved in human heart failure. J Appl Physiol 104:952-7
VanBuren, Peter; Okada, Yoko (2005) Thin filament remodeling in failing myocardium. Heart Fail Rev 10:199-209
Hunlich, Mark; Begin, Kelly J; Gorga, Joseph A et al. (2005) Protein kinase A mediated modulation of acto-myosin kinetics. J Mol Cell Cardiol 38:119-25
Noguchi, Teruo; Hunlich, Mark; Camp, Phillip C et al. (2004) Thin-filament-based modulation of contractile performance in human heart failure. Circulation 110:982-7
Noguchi, Teruo; Kihara, Yasuki; Begin, Kelly J et al. (2003) Altered myocardial thin-filament function in the failing Dahl salt-sensitive rat heart: amelioration by endothelin blockade. Circulation 107:630-5
Noguchi, Teruo; Camp Jr, Phillip; Alix, Shari L et al. (2003) Myosin from failing and non-failing human ventricles exhibit similar contractile properties. J Mol Cell Cardiol 35:91-7
Gorga, Joseph A; Fishbaugher, David E; VanBuren, Peter (2003) Activation of the calcium-regulated thin filament by myosin strong binding. Biophys J 85:2484-91
VanBuren, Peter; Alix, Shari L; Gorga, Joseph A et al. (2002) Cardiac troponin T isoforms demonstrate similar effects on mechanical performance in a regulated contractile system. Am J Physiol Heart Circ Physiol 282:H1665-71
Lewinter, Martin M; Vanburen, Peter (2002) Myofilament remodeling during the progression of heart failure. J Card Fail 8:S271-5